Department of Cranio-Maxillofacial Surgery, Hannover Medical School, Carl-Neuberg-Street 1, Hannover, D-30625, Germany.
World J Surg Oncol. 2012 Nov 22;10:253. doi: 10.1186/1477-7819-10-253.
Cervical metastasis has a tremendous impact on the prognosis in patients with carcinomas of the head and neck and the frequency of such spread is greater than 20% for most squamous cell carcinomas. With emerging evidence, focus is shifting to conservative neck procedures aimed at achieving good shoulder function without compromising oncologic safety. The purpose of this study was to analyze the pattern of nodal metastasis in patients presenting with squamous cell carcinoma of buccal mucosa.
This was a prospective clinical analysis of patients who were histologically diagnosed with squamous cell carcinoma of the buccal cavity and clinically N1 and had not received treatment anywhere else. Patients were analyzed for age and sex distribution, tumor staging, location, and metastasis.
The incidence of metastatic lymph node in T4 (n=44) was the highest, that is, level I was 100% (44/44), level II was 43.18% (19/44), level III was 15.90% (7/44), and level IV was 4.5% (2/44). Level V was free of metastasis. Among T3 (n=10) lesions, incidence of metastasis in level I was 100% (10/10), level II was 20% (2/10), and level III, IV, and V were free of metastasis. Among T2 (n=6) lesions, incidence of lymph node metastasis in level I was 100% (6/6) and all other levels of lymph nodes were found free of metastasis.
Lymphatic spread from carcinoma of the buccal mucosa is low. Involvement of level IV is seen in only 3% of patients. A more conservative approach to the neck in patients with carcinoma of the buccal mucosa is recommended.
颈部转移对头颈部癌患者的预后有重大影响,大多数鳞状细胞癌的转移频率超过 20%。随着新证据的出现,焦点正在转向旨在实现良好肩部功能而不影响肿瘤安全性的保守颈部手术。本研究的目的是分析颊黏膜鳞状细胞癌患者的淋巴结转移模式。
这是一项对组织学诊断为颊腔鳞状细胞癌且临床 N1 且未在其他任何地方接受治疗的患者进行的前瞻性临床分析。对患者的年龄和性别分布、肿瘤分期、位置和转移进行分析。
T4(n=44)转移淋巴结的发生率最高,即 I 水平为 100%(44/44),II 水平为 43.18%(19/44),III 水平为 15.90%(7/44),IV 水平为 4.5%(2/44),V 水平无转移。T3(n=10)病变中,I 水平转移发生率为 100%(10/10),II 水平为 20%(2/10),III、IV 和 V 水平无转移。T2(n=6)病变中,I 水平淋巴结转移发生率为 100%(6/6),其他所有水平的淋巴结均未见转移。
颊黏膜癌的淋巴扩散较低。仅 3%的患者出现 IV 级淋巴结受累。建议对颊黏膜癌患者采用更保守的颈部处理方法。